SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-058436
Filing Date
2023-11-03
Accepted
2023-11-02 18:33:43
Documents
65
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acad-20230930.htm   iXBRL 10-Q 2224159
2 EX-31.1 acad-ex31_1.htm EX-31.1 11607
3 EX-31.2 acad-ex31_2.htm EX-31.2 11804
4 EX-32.1 acad-ex32_1.htm EX-32.1 8357
5 EX-32.2 acad-ex32_2.htm EX-32.2 8415
  Complete submission text file 0000950170-23-058436.txt   8599110

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acad-20230930_lab.xml EX-101.LAB 399268
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acad-20230930.xsd EX-101.SCH 52944
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acad-20230930_cal.xml EX-101.CAL 55001
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acad-20230930_pre.xml EX-101.PRE 297641
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acad-20230930_def.xml EX-101.DEF 153167
59 EXTRACTED XBRL INSTANCE DOCUMENT acad-20230930_htm.xml XML 1751117
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 231373954
SIC: 2834 Pharmaceutical Preparations